3 | SEC Filings Hub

Filing metadata

Accession number: 0001600620-24-000112
Form type: Form 3
Filer: Aurinia Pharmaceuticals Inc.
CIK: CIK 1600620
Filed: Nov 12, 2024
Reporting period: Nov 07, 2024
Description: Initial ownership

Documents

0001600620-24-000112-index.htm

Complete submission

0001600620-24-000112.txt

directory listing

Filed by

Aurinia Pharmaceuticals Inc.